SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-082120
Filing Date
2017-03-14
Accepted
2017-03-14 16:59:55
Documents
3
Period of Report
2017-03-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d362248d8k.htm 8-K 19573
2 EX-99.1 d362248dex991.htm EX-99.1 10888
3 GRAPHIC g362248g0314105119838.jpg GRAPHIC 2342
  Complete submission text file 0001193125-17-082120.txt   35219
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 17688782
SIC: 2836 Biological Products, (No Diagnostic Substances)